Hello ALL!!
That Mark Cuban news was interesting and then I saw that Cost Plus pop-up again in my Becker Articles that a lot of Health Professionals receive daily, I was hoping for mention of us in it, as it said Digital Health Company and I know we are somewhat considered that according to management. But it wasn't us, but still felt the partnership had some meaning in the Pharmaceutical world if Becker's was reporting on it. They usually report on notable stories.

Becker Article
Looks like another partner with similar plans.
Cost Plus Drugs partners with digital health company

Mark Cuban Cost Plus Drug Co. has partnered with digital health company Expion Health in an effort to tackle the rising costs of specialty drugs.

Under the new partnership, Cost Plus Drug Co. will integrate its pricing model — which prices drugs at a 15% markup and charges a $5 shipping and a $5 pharmacy operations fee — into Expion Health's digital product platform to provide a tool for payers to navigate cost options for consumers, according to a Nov. 27 news release from Expion.

Chris Westbrook, chief client officer for Expion Health, said in the release the two companies share similar visions and that the newly inked collaboration represents how they can begin "reshaping the narrative around drug costs, setting a new industry standard."

The right incentives are there, they obviously feel like they can get this to go places in terms of stock price or why go that route for stock options. I really like this from a positive perspective for all current and future shareholders of RXMD.

All is going well. Thanks!

Thanks for sharing Stockforce, that video was great to see, platform looks pretty good and easy to use, and new Pharmacy space looks amazing too.

This a move I can get behind, we needed this to enhance our shareholder value. We are profitable, let's get this out to the investment world.

Sell all your preloaded shares and then I will buy millions of shares.

That's positive news. Have preached that to him many times in emails that the SPARK needed to go away.

Because we still had the convertible debt. Were you not listening, December 3rd is just a vote like before, not the reverse split. I would have felt more comfortable with 10 to 100, but the kicker was the renegotiation to freeze Illiad and the convertible. Back in May it would have killed us. If we can get them on a conversion freeze, you have seen the impact that has had on share price in the past. We move up. We have 2 million in cash, I would rather see us pay their asses off without conversion and with the capital raise, they would be gone pretty quickly.

Looking forward to call this afternoon.

Are you kidding me Mike,he got those in exchange for $20k debt. He has already taken his free shares,40 million of them. Those were granted just so that he could have Super voting power. That's it. They are even labeled as such in Financial Statements.

My concern, that's why I want it addressed.

But why are they converting to commons, those were designed just for Super-Voting Preferred. Why not just eliminate them all together? That is my real question.

Here is what I have come up with so far?

Has Benchmark officially raised the $10 million in capital?

What is your target share price before enacting a reverse split?

What is range of new reverse split proposal for proxy vote?

Any merger news?

How do you plan to expand without dilution?

When do you plan on pulling in profits?

When do we anticipate NASDAQ uplist?

How much of the Chicago Ventures/Illiad Debt do you plan to pay off, principle balance at 6/30/21 was $1,759,700 and with Accrued Interest of $712,411? The 12.5% of Net Proceeds only represents 50% of outstanding debt. What is being used to cover the rest before March 2022?

Have there been any new revenues attributed to ClearMetrX?

Have there been any recent 340B Institution Additions/Deletions?

How is “myVax” intended to create revenues?

What will our business look like in the next 3 years going forward as a result of management's plan to grow and/or change our services.

Will you need to revise the S-1 due to Oleg Firer’s employment status change with Net Element and do they need to add Q3 financials in the revised S-1.

What’s this about conversion of Preferred Voting Shares to a Trust? These were designed just for voting control purposes, why would there be a conversion to common stock, hence any need for a Trust other than to hold these Preferred Shares in event of delist?

Feeling little energetic here, sorry for those of you down with the VID, but I am actually looking forward to this call, thinking they might actually share something with us. I guess we need to submit our questions if we want anything answered though. Anybody have any they want answered that I can group into mine, to save you some time.

$APRE 8 Catalyst on the way not including the potential buyout here. CEO Chris Schlade has sold his last 3 companies to BIG PHARMA. A lot of trials on going that have had "KNOCK YOUR SOCKS OFF RESULTS" Come see us on ST for more information and great DD.

https://sec.report/Document/0001213900-21-052155/

I will have to say the trading activity here lately has been quite intriguing.

$RXMD DD Quick Summary [OTCQB]

Knowing what we know from the below, I totally agree!!!

Hello Investors

RXMD Audited F/S for 5 years running!

RXMD OTCQB and Penny Stock EXEMPT Classification

SEC Confidential S1 was filed in November 2020

RXMD Prescriptions Filled and Annual Net Revenues Actual and Estimate for FY21

RXMD Reconciliation of Net Loss for FY2020 – Check out Change Throughout Year (During COVID)

RXMD Debt Balances and Change over the last 2 Years. Fantastic Job on Elimination of Debt

RXMD Pharmacy Locations and Employee Base

RXMD State Licenses and Locations

RXMD 5 Year Share Price History

Agree Totally. As for Armen they have continued to state that the SEC Registration is underway and the management team is working diligently on completing everything they have mentioned.

Armen and RXMD Management are stilling pursuing everything they stated.

Looking into the past, I know how to read financial statements, other part-time investors in RXMD, not so much.




NOT SO MUCH.......

Capt, that's only when RXMD converts shares to ILLIAD at that calculated price, it is not for when ILLIAD converts shares on the open market.

Still haven't shown us where S1 has changed.

Again that doesn't affect the S1 at all.
That means for now the Uplist is on hold.

We have many reports stating the S1 is on, but none stating that it isn't. You can use my RXMD DD link to show that it is on.

Tell me how S1 and reverse split are in anyway related. They are not. Don't need a reverse split for an S1.

Good morning fellow RXMDers.

$RXMD DD Quick Summary [OTCQB]
Hello Investors

RXMD Audited F/S for 5 years running!

RXMD OTCQB and Penny Stock EXEMPT Classification

SEC Confidential S1 was filed November 9, 2020



RXMD Prescriptions Filled and Annual Net Revenues Actual and Estimate for FY21

RXMD Reconciliation of Net Loss for FY2020 – Check out Change Throughout Year (During COVID)

RXMD Debt Balances and Change over the last 2 Years. Fantastic Job on Elimination of Debt

RXMD Pharmacy Locations and Employee Base

RXMD State Licenses and Locations

RXMD 5 Year Share Price History

$RXMD DD Quick Summary [OTCQB]
Hello Investors

RXMD Audited F/S for 5 years running!

RXMD OTCQB and Penny Stock EXEMPT Classification

SEC Confidential S1 was filed in November 2020



RXMD Prescriptions Filled and Annual Net Revenues Actual and Estimate for FY21

RXMD Reconciliation of Net Loss for FY2020 – Check out Change Throughout Year (During COVID)

RXMD Debt Balances and Change over the last 2 Years. Fantastic Job on Elimination of Debt

RXMD Pharmacy Locations and Employee Base

RXMD State Licenses and Locations

RXMD 5 Year Share Price History

SEEING THE BIG TRADING MISTAKE THAT WAS MADE


Wednesday, 01/24/18 10:13:51 AM
Re: None
Post #
66381
of 169448
A new day at RXMD ...3M RXMD Bid Support will be at .013. Have a great Day.


IT NEVER GOT BELOW $.02 AGAIN and moved up so quickly, attempt to catch the train was missed.

Or how many millions did they profit by holding past $.019. Or how much potential do they still have by holding onto their shares and actually still owning shares. Seems as if that more than one trade and "making money" bogus claim was put to bed pretty quickly. LMAOROTF

Or how many millions did they profit by holding past $.019. Or how much potential do they still have by holding onto their shares and actually still owning shares. LMAOROTF

Man if that is the case, why would anyone ever sell at $.019 LMAOROTF

LOL, I love this one.

Find it really hard to manipulate Information and Filings when they have been audited by respectable Auditing firms for the last 5 years.

$RXMD DD Quick Summary [OTCQB]
Hello Investors

RXMD Audited F/S for 5 years running!


RXMD OTCQB and Penny Stock EXEMPT Classification


SEC Confidential S1 was filed in November 2020


RXMD Prescriptions Filled and Annual Net Revenues Actual and Estimate for FY21


RXMD Reconciliation of Net Loss for FY2020 – Check out Change Throughout Year (During COVID)


RXMD Debt Balances and Change over the last 2 Years. Fantastic Job on Elimination of Debt


RXMD Pharmacy Locations and Employee Base


RXMD State Licenses and Locations


RXMD 5 Year Share Price History

So they have all this cash on hand, I thought it was just flying out the doors and windows for company expenses. I think the COH balance proves a point.

And....Thank God they are continuing to implement a business strategy. Like every other business in the world should be doing.

From 1 location to 4 in that last 3 years. From 20 million annual net revenues to over $40 million annual net revenues in the last 3 years. Shame on them though I guess.

Statements only support why investors who don't understand DD would sell 2 million shares @ $.019 before a move to $.267. Poor business strategy.

I hope you know that Cash received from either of those has absolutely nothing to do with Loss from Operations. And that when you remove the non-cash transactions (derivatives, depreciation, and interest expense) from those items that the company turned a profit for the last 3 quarters and for FY 2020 as a whole. So you keep focusing on Net Loss, when they have the Derivative outstanding and I will focus on actual operations and where they stand excluding the non-cash GAAP transactions, that companies use to not even have to report until the last few years.

Also, RXMD is siting on $2,400,000 as of March 31, 2021. Why so much Cash on Hand, if they are just trucking through it to pay for expenses? That's right, the cash from Fife was already used for still intended for Expansion and as for PPP money, the cash has to be used for the intended purpose of supporting the business during Covid period. It has to be used for the intended purpose to obtain forgiveness of the debt. All of your statements are a pointless.